Jazz Pharmaceuticals Denmark ApS: Financial statements 2024
CVR: 39791447
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Jazz Pharmaceuticals Denmark ApS (CVR 39791447) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 36,708,802 and a net result of DKK 1,538,214 compared with DKK 595,176 the year before. That is an increase of 15.5% compared with the year before. Equity in the 2024 report amounted to DKK 12,295,111. The solvency ratio was 37.9%. The company had 18 employees in the financial year.
- Gross Profit
- DKK 36,708,802
- Profit/Loss
- DKK 1,538,214
- Equity
- DKK 12,295,111
- Total Assets
- DKK 32,452,498
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 36.7 mio. | 1.5 mio. | 12.3 mio. | 18 |
| 2023 | - | 31.8 mio. | 595 t. | 10.8 mio. | 17 |
| 2022 | - | 30.4 mio. | 2 mio. | 10.2 mio. | 16 |
| 2021 | - | 21.7 mio. | 560 t. | 8.2 mio. | 10 |
| 2020 | - | 16.5 mio. | 1.5 mio. | 7.6 mio. | 14 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Jazz Pharmaceuticals Denmark ApS has won the tender "Amgros 2025 1.1304.a" issued by Amgros I/S worth 83,949,231 DKK.
Jazz Pharmaceuticals Denmark ApS has won the tender "Amgros 2025 1.201.a" issued by Amgros I/S worth 149,993,922 DKK.
Jazz Pharmaceuticals Denmark ApS has published its annual report for 2023. Gross profit came to DKK 31,787,838, and the net result was DKK 595,176.
Jazz Pharmaceuticals Denmark ApS has won the tender "Amgros 2024 1.150.a" issued by Amgros I/S worth 73,756,763 DKK.
About Jazz Pharmaceuticals Denmark ApS
Jazz Pharmaceuticals Denmark ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of David James Spackman and Kamilla Enggaard Have. The company is owned by Jazz Pharmaceuticals Ireland Holdings Limited. The company has 13 employees (2026). In 2025, the company reported a gross profit of DKK 41,044,332 and a net result of DKK 1,528,396 compared with DKK 1,538,214 the year before. Equity in the 2025 report amounted to DKK 13,823,507.